OncLive® On Air
OncLive® On Air
In OncLive® On Air, you can expect to hear interviews with academic oncologists on the thought-provoking oncology presentations they give at the OncLive® State of the Science Summits. The topics in oncology vary, from systemic therapies, surgery, radiation therapy, to emerging therapeutic approaches in a particular type of cancer. This includes lung cancer, breast cancer, gastrointestinal cancers, hematologic malignancies, gynecologic cancers, genitourinary cancers, and more.
Episodes
Mentioned books
Dec 9, 2021 • 16min
S6 Ep16: Coombs Previews Anticipated ASH Abstracts in CLL
Dr. Coombs discusses research that will be presented at the upcoming 2021 ASH Annual Meeting and Exposition in chronic lymphocytic leukemia, including that with covalent and noncovalent BTK inhibitors, COVID-19 vaccinations, and time-limited combinations.
Dec 6, 2021 • 12min
S6 Ep15: FDA Approval Insights: Adjuvant Pembrolizumab in RCC
Dr. Choueiri discusses the significance of the FDA approval of pembrolizumab as adjuvant therapy in renal cell carcinoma and key data from the pivotal phase 3 KEYNOTE-564 trial.
Dec 2, 2021 • 47min
S6 Ep14: Bleicher and Nardello Talk About Finding the Best Fit for Fellowship in Oncology
Dr. Bleicher and Dr. Nardello discuss the process of finding a mentor, what to look for in a fellowship program, and the benefits of fellowship for both academic and community oncologists.
Nov 29, 2021 • 17min
S6 Ep13: Roychowdhury Relays Impact of Recent Infigratinib Approval in FGFR+ Cholangiocarcinoma
Sameek Roychowdhury, MD, PhD, discusses the pivotal phase 2 trial with infigratinib in FGFR-positive cholangiocarcinoma, the safety and efficacy achieved with infigratinib, and the next steps for this agent.
Nov 25, 2021 • 24min
S6 Ep12: Katona Highlights the Hallmarks of Hereditary Diffuse Gastric Cancer
Bryson Katona, MD, of Penn Medicine, discusses the hallmarks of hereditary diffuse gastric cancer.
Nov 22, 2021 • 26min
S6 Ep11: Marvels in Medicine: Allison Talks Everything from Advances in Immunotherapy to Jamming With Willie Nelson
Dr. Allison highlights everything from his proudest professional moments, to MD Anderson’s Moon Shot program, to his musical talents, to next steps he’s taking in cancer research.
Nov 18, 2021 • 18min
S6 Ep10: Kalyan and Mouli Provide Perspective on the Power of Personalized Medicine in HCC
Dr. Kalyan and Dr. Mouli discuss the importance of multidisciplinary care in hepatocellular carcinoma, data regarding real-world personalization treatment recommendations, and the benefits of decision-making analysis tools in the space.
Nov 15, 2021 • 12min
S6 Ep9: Ku Reviews Exciting ESMO Data in Gastric/GEJ Cancer
Dr. Ku underscores key takeaways from the CheckMate649 and DESTINY-Gastric02 trials in gastric/GEJ cancer and highlights ongoing research that has the potential to further inform treatment selection and sequencing in the field
Nov 11, 2021 • 11min
S6 Ep8: Gradishar Gives Insight Into the Growing Role of SERDs in Breast Cancer
Dr. Gradishar discusses the evolution of SERDs in breast cancer, novel SERDs that could shift the paradigm of breast cancer treatment, and ongoing research that could solidify the role of these agents in the field.
Nov 8, 2021 • 21min
S6 Ep7: Tagawa Breaks Down FGFR Testing and the Use of Erdafitinib in Bladder Cancer
Dr. Tagawa discusses the incidence and identification of FGFR alterations in bladder cancer, the approval and use of erdafitinib in the second-line setting for patients with advanced bladder cancer, and research directions with the FGFR inhibitor in the field.
